Market conditions in the shrimp and seabass/bream sectors led to what it described as a "disappointing" financial year for aquaculture health, nutrition and genetics business Benchmark.
Unaudited figures released today reveal that the company expects fourth quarter earnings before interest, tax, depreciation and amortization (EBITDA) in the range of £7 million (€8.2
